CD Media

Pfizer Quietly Adds Language Warning That ‘Unfavorable Pre-Clinical, Clinical Or Safety Data’ May Impact Business

Anthony Fauci’s Trench Warfare Approach To Covid-19

Please Follow us on GabMindsTelegramRumbleGab TVGETTR

Two weeks ago, the FDA begged a Texas judge to delay production on the first monthly batch of 55,000 pages of Covid-19 vaccine data submitted to the agency by Pfizer. Originally, the agency was set to produce just 500 pages-per-month.

Now, Pfizer – which just forecast $54 billion in Covid-related sales in 2022, appears to be anticipating some bad newsas evidenced by several redline changes in their Q4 earnings releases.

As Rubicon Capital’s Kelly Brown notes on Twitter, the changes center around disclosures of unfavorable safety data.

For example, in Q4 they added: “or further information regarding the quality of pre-clinical, clinical or safety data, including by audit or inspection.”

To read more visit Zero Hedge.

We simply need your help to continue bringing the truth…shameless plug for desperately needed donations at this link…

Related posts

Russian Authorities Disagree Over Lifting Telegram Ban

CD Media Staff

Pfizer Executive: ‘Mutate’ COVID Via ‘Directed Evolution’ For Company To Continue Profiting Off Of Vaccines

CD Media Staff

O’KEEFE V. TWITTER LEGAL VICTORY: Defeats Attempt To Transfer Case To Friendly Court

CD Media Staff

Leave a Comment

Subscribe to our evening newsletter to stay informed during these challenging times!!